• 1
    Girön JA, Alvarez-Mon M, Menéndez-Caro JL, Abreu L, Albillos A, Manzano L, et al. Increased spontaneous and lymphokine-conditioned IgA and IgG synthesis by B cells from alcoholic cirrhotic patients. HEPATOLOGY 1992; 16: 664-670.
  • 2
    Albillos A, de la Hera A, Gonzalez M, Moya JL, Calleja JL, Monserrat J, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. HEPATOLOGY 2003; 37: 208-217.
  • 3
    Albillos A, de la Hera A, Reyes E, Monserrat J, Munoz L, Nieto M, et al. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin. J Hepatol 2004; 40: 624-631.
  • 4
    Chedid A, Mendenhall CL, Moritz TE, French SW, Chen TS, Morgan TR. Expression of the beta 1 chain (CD29) of integrins and CD45 in alcoholic liver disease. The VA Cooperative Study Group No. 275. Am J Gastroenterol 1993; 88: 1920-1927.
  • 5
    Lopez-Talavera JC, Levitzki A, Martinez M, Gazit A, Esteban R, Guardia J. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites. J Clin Invest 1997; 100: 664-670.
  • 6
    Muñoz J, Albillos A, Perez-Paramo M, Rossi I, Alvarez-Mon M. Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive rats. Am J Physiol 1999; 276: G693-G697.
  • 7
    Wiest R, Das S, Cadelina G, Garcia-Tsao G, Milstien S, Groszmann RJ. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest 1999; 104: 1223-1233.
  • 8
    Genesca J, Marti R, Rojo F, Campos F, Peribanez V, Gonzalez A, et al. Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites. Gut 2003; 52: 1054-1059.
  • 9
    Albillos A, de-la-Hera A. Multifactorial gut barrier failure in cirrhosis: working out the role of probiotics and antioxidants. J Hepatol 2002; 37: 523-526.
  • 10
    Runyon BA, Borzio M, Young S, Squier SU, Guarner C, Runyon MA. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. HEPATOLOGY 1995; 21: 1719-1724.
  • 11
    Albillos A, de la Hera A, Alvarez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet 2004; 363: 1608-1610.
  • 12
    MacKay CR, Marston W, Dudler L. Altered patterns of T-cell migration through lymph nodes and skin following antigen challenge. Eur J Immunol 1992; 22: 2205-2210.
  • 13
    Carter PB, Collins FM. The route of enteric infection in normal mice. J Exp Med 1974; 139: 1189-1203.
  • 14
    Young AJ. The physiology of lymphocyte migration through the single lymph node in vivo. Semin Immunol 1999; 11: 73-83.
  • 15
    Ramirez F, Mason D. Recirculatory and sessile CD4+ T lymphocytes differ on CD45RC expression. J Immunol 2000; 165: 1816-1823.
  • 16
    Runyon B, Sugano S, Kanel G, Mellencamp M. A rodent model of cirrhosis, ascites, and bacterial peritonitis. Gastroenterology 1991; 100: 489-493.
  • 17
    Perez-Paramo M, Muñoz J, Albillos A, Freile I, Portero F, Santos M, et al. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. HEPATOLOGY 2000; 31: 43-48.
  • 18
    Palmblad K, Andersson U. Identification of rat IL-1beta, IL-2, IFN-gamma and TNF-alpha in activated splenocytes by intracellular immunostaining. Biotech Histochem 2000; 75: 101-109.
  • 19
    Sojka DK, Bruniquel D, Schwartz RH, Singh NJ. IL-2 Secretion by CD4+ T cells in vivo is rapid, transient, and influenced by TCR-specific competition. J Immunol 2004; 172: 6136-6143.
  • 20
    Brocker T, Gulbranson-Judge A, Flynn S, Riedinger M, Raykundalia C, Lane P. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur J Immunol 1999; 29: 1610-1616.
  • 21
    Weinberg AD, Wallin JJ, Jones RE, Sullivan TJ, Bourdette DN, Vandenbark AA, et al. Target organ-specific up-regulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis. J Immunol 1994; 152: 4712-4721.
  • 22
    Matsuura A, Kinebuchi M, Chen HZ, Katabami S, Shimizu T, Hashimoto Y, et al. NKT cells in the rat: organ-specific distribution of NK T cells expressing distinct V alpha 14 chains. J Immunol. 2000; 164: 3140-3148.
  • 23
    Subra JF, Cautain B, Xystrakis E, Mas M, Lagrange D, van der Heijden H, et al. The balance between CD45RChigh and CD45RClow CD4 T cells in rats is intrinsic to bone marrow-derived cells and is genetically controlled. J Immunol 2001; 166: 2944-2952.
  • 24
    Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2357.
  • 25
    Koerner TJ, Adams DO, Hamilton TA. Regulation of tumor necrosis factor (TNF) expression: interferon-gamma enhances the accumulation of mRNA for TNF induced by lipopolysaccharide in murine peritoneal macrophages. Cell Immunol 1987; 109: 437-443.
  • 26
    Nakamura K, Okamura H, Wada M, Nagata K, Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun 1989; 57: 590-595.
  • 27
    Ahn HJ, Maruo S, Tomura M, Mu J, Hamaoka T, Nakanishi K, et al. A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J Immunol 1997; 159: 2125-2131.
  • 28
    Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Reinhardt RL, et al. In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 2001; 19: 23-45.
  • 29
    Balazs M, Martin F, Zhou T, Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 2002; 17: 341-352.